Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
US8586565B2 · kind B2 · utility
52Cited by
0References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2010 |
| Grant date | Nov 19, 2013 |
| Priority date | — |
| Expiry date | Jul 30, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with novel compounds useful in the treatment of hyperproliferative diseases and mammalian cancers, especially human cancers. The invention also pertains to methods of modulating kinase activities, pharmaceutical compositions, and methods of treating individuals, incorporating or using the compounds. The preferred compounds are active small molecules set forth in formulae Ia-Iww.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.